HLA Alleles and Amino-Acid Signatures of the Peptide-Binding Pockets of HLA Molecules in Vitiligo-Reference-Cited by-同舟云学术

HLA Alleles and Amino-Acid Signatures of the Peptide-Binding Pockets of HLA Molecules in Vitiligo

Published:2012-01 Issue:1 Volume:132 Page:124-134
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Singh Archana,Sharma Pankaj,Kar Hemanta K.,Sharma Vinod K.,Tembhre Manoj K.,Gupta Somesh,Laddha Naresh C.,Dwivedi Mitesh,Begum Rasheedunnisa,The Indian Genome Variation Consortium ,Gokhale Rajesh S.,Rani Rajni

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference43 articles.

1. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families;Alkhateeb;Pigment Cell Res,2003

2. Evaluation of two methods for computational HLA haplotypes inference using a real dataset;Bettencourt;BMC Bioinformatics,2008

3. Genetic nature of vitiligo;Bhatia;J Dermatol Sci,1992

4. Occurrence rates of HLA-DRB1, HLA-DQB1, and HLA-DPB1 alleles in patients suffering from vitiligo;Buc;Eur J Dermatol,1998

5. The Indian Genome Variation database (IGVdb): a project overview;Consortium;Hum Genet,2005

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HLA inherence as a potential parameter in checkpoint inhibitor-associated autoimmune adverse event assessment;Frontiers in Medicine;2024-01-08

2. Vitiligo: Pathogenesis, Clinical Features, and Treatment;Pigmentation Disorders - Etiology and Recent Advances in Treatments;2023-03-15

3. Current paradigms of pathogenesis and challenges in vitiligo translational research;Translational Autoimmunity;2023

4. V-set domain containing T-cell activation inhibitor-1 (VTCN1): A potential target for the treatment of autoimmune diseases;Immunobiology;2022-11

5. Current Debates on Etiopathogenesis and Treatment Strategies for Vitiligo;Current Drug Targets;2022-10